High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach.
Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are...
Main Authors: | Nisha B Shah, Rhonita E Mitchell, Stephanie Terry Proctor, Leena Choi, Joshua DeClercq, Jacob A Jolly, Anna R Hemnes, Autumn D Zuckerman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217798 |
Similar Items
-
Pharmacist Interventions to Improve Specialty Medication Adherence: Study Protocol for a Randomized Controlled Trial
by: Amanda M. Kibbons, et al.
Published: (2020-09-01) -
Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies
by: Academia, E.C, et al.
Published: (2021) -
Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies
by: Canfield, S., et al.
Published: (2021) -
Impact of a Specialty Pharmacy-Based Oral Chemotherapy Adherence Program on Patient Adherence
by: Russell, Kathy, et al.
Published: (2016) -
Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy
by: Banks, A., et al.
Published: (2021)